Dr. Sonia Vallet

Dr. Sonia Vallet

Forschungsteam "Signal Transduction and the Tumor Microenvironment"

+43 2732 9004 2555

+43 2732 9004 5555

sonia.vallet@krems.lknoe.at

Publikationen

2019
- Zeitschriftenartikel
  - Li, S., Vallet S., Sacco A., Roccaro A., Lentzsch S., & Podar K.
    (2019). Targeting transcription factors in multiple myeloma: evolving therapeutic strategies.
    Expert Opin Investig Drugs. 28, 445-462.
    Link
  - Vallet, S., Fan F., Malvestiti S., Pecherstorfer M., Sattler M., Schneeweiss A., et al.
    (2019). Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
    Breast Cancer Res Treat. 173, 585-596.
    Link
2018
- Zeitschriftenartikel
  - Vallet, S., Fan F., Malvestiti S., Pecherstorfer M., Sattler M., Schneeweiss A., et al.
    (2018). Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
    Breast Cancer Research and Treatment.
    Link
  - Vallet, S., Filzmoser J. M., Pecherstorfer M., & Podar K.
    (2018). Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies.
    Pharmaceutics. 10, 202.
  - Vallet, S., Hoyle N. R., Kyle R. A., Podar K., & Pecherstorfer M.
    (2018). A role for bone turnover markers beta-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.
    Leukemia & Lymphoma. 59, 2431-2438.
    Link
2017
- Zeitschriftenartikel
  - Fan, F., Bashari M. H., Morelli E., Tonon G., Malvestiti S., Vallet S., et al.
    (2017). The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment.
    Leukemia. 31, 1570-1581.
    Link
  - Rosenberger, F., Wiskemann J., Vallet S., Haag G. M., Schembri E., Jager D., et al.
    (2017). Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy-a controlled feasibility trial.
    Support Care Cancer. 25, 3655-3664.
    Link
  - Vallet, S., Pecherstorfer M., & Podar K.
    (2017). Adoptive cell therapy in multiple Myeloma.
    Expert Opinion on Biological Therapy. 17, 1511-1522.
    Link

Informationen für

Publikationen

2019

Zeitschriftenartikel

2018

Zeitschriftenartikel

2017

Zeitschriftenartikel

Aktuelles

ESB Conference 2019

Funktionsperiode des KL Rektorates wurde verlängert

20 Jahre Österreichische Privatuniversitäten

Events

Phage Konferenz

KL Symposium - "20 Jahre Bologna-Prozess"

Akademische Feier - BACHELOR HEALTH SCIENCES

Kontakt